IceCure Medical Ltd

AI Score

0

Unlock

1.50
-0.05 (-3.23%)
At close: Feb 20, 2025, 3:59 PM
1.50
-0.33%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined%
Bid 1.43
Market Cap 82.44M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.28
PE Ratio (ttm) -5.37
Forward PE n/a
Analyst Buy
Ask 1.54
Volume 344,245
Avg. Volume (20D) 486,847
Open 1.55
Previous Close 1.55
Day's Range 1.44 - 1.55
52-Week Range 0.48 - 1.66
Beta undefined

About ICCM

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel....

Sector Healthcare
IPO Date Aug 26, 2021
Employees 71
Stock Exchange NASDAQ
Ticker Symbol ICCM
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for ICCM stock is "Buy." The 12-month stock price forecast is $2.7, which is an increase of 79.40% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

IceCure Medical Ltd is scheduled to release its earnings on Apr 2, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+18.18%
IceCure Medical shares are trading higher after th... Unlock content with Pro Subscription
6 months ago
+18.18%
IceCure Medical shares are trading higher after the company reported better-than-expected Q2 financial results.